Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-142
LL-37 5 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-142
Active Batch Lot
Recovery & Tissue Repair • In stock — Ready to ship

LL-37 (5 mg)

€54 5 mg • EUR

LL-37 is the sole human cathelicidin antimicrobial peptide (37 residues, amphipathic α-helix), investigated extensively in innate immunity, bacterial biofilm disruption, LPS neutralization, and wound re-epithelialization.

Chemical & Registry Specifications
CAS Registry Number 154947-66-7
Molecular Formula C205H340N60O53
Molecular Weight 4493.26 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (37-aa human cathelicidin)
Primary Biological Target / Pathway Antimicrobial membrane disruption, FPR2 chemotaxis & biofilm inhibition
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: LL-37

LL-37 is the sole human cathelicidin antimicrobial peptide (37 residues, amphipathic α-helix), investigated extensively in innate immunity, bacterial biofilm disruption, LPS neutralization, and wound re-epithelialization.

Full 37-residue cationic amphipathic sequence (4493.26 Da)
Acetate counterion prevents TFA interference in MIC assays
Verified sequence fidelity via RP-HPLC & ESI-MS
Primary Literature Reference Dürr U.H.N. et al., Biochim Biophys Acta (2006) — LL-37 structure and host-defense antimicrobial activity (PMID: 16759636)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-142)

Analytical release verification for current LL-37 (5 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-142 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.0% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile water or 0.9% Bacteriostatic Water; avoid high-salt precipitation at concentrated stocks

Temperature & Stability

Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 21 days.

LL-37 — Technical Questions & Answers

What is the molar concentration when reconstituting LL-37 (5 mg) in 2.0 mL?

Reconstituting the full 5 mg vial of LL-37 (MW 4493.26 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.56 mM (556 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does LL-37's counterion stoichiometry affect assay mass calculations?

LL-37 (CAS 154947-66-7, formula C205H340N60O53) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify LL-37 Lot SL-2026-142 and what pathway does it target?

Lot SL-2026-142 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 4493.26 g/mol. In preclinical literature, LL-37 targets Antimicrobial membrane disruption, FPR2 chemotaxis & biofilm inhibition (Dürr U.H.N. et al., Biochim Biophys Acta (2006) — LL-37 structure and host-defense antimicrobial activity (PMID: 16759636)).

Research Use Only (RUO): LL-37 is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related Recovery & Tissue Repair Compounds

View category →
≥99.0%
ARA 290 16 mg — ≥99.0% Research Vial
ARA 290
16 mg In stock
CAS 1208243-50-8
MW: 1257.31 g/mol
€52
≥99.2%
BPC-157 5 mg — ≥99.2% Research Vial
BPC-157
5 mg In stock
CAS 137525-51-0
MW: 1419.53 g/mol
€38
≥99.0%
BPC-157 5mg + TB-500 5mg 5mg + 5mg — ≥99.0% Research Vial
BPC-157 5mg + TB-500 5mg
5mg + 5mg In stock
CAS 137525-51-0 / 77591-33-4
MW: 1419.53 g/mol & 4963.50 g/mol
€56

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog